Literature DB >> 24835804

Trismus and diffuse polymyalgia: an unusual presentation of recurrent metastatic ovarian cancer.

Ramsis Benjamin1, Jing Zhai2, Robert Morgan3, Neal Prakash1.   

Abstract

A 22-year-old woman first presented in 2009 with abdominal distention. The diagnosis of stage IA right ovarian tumour was made by fertility-sparing surgery. In the subsequent years, the involvement of the left ovary and metastasis to the lungs prompted further surgical intervention and chemotherapy. By 2013, she experienced insidious, debilitating and diffuse musculoskeletal pain with trismus. Polymyositis or diffuse radiculitis was suspected. Imaging studies identified enhancing lesions in the thigh musculature, temporalis, parotid gland, pterygoid, masseter, tongue, cerebellum and leptomeninges. Biopsy of one of the thigh lesions confirmed the diagnosis of mucinous adenocarcinoma. She succumbed to the disease in November 2013. This case illustrates the aggressive nature of mucinous epithelial ovarian cancer and its resilience to conventional chemotherapy. On account of its high death rate, it is recommended that the epithelial-mesenchymal transition be researched and early therapy targeted at the k-ras oncogene initiated in spite of the tumour's lower initial staging. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24835804      PMCID: PMC4025373          DOI: 10.1136/bcr-2013-203361

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  25 in total

1.  Ovarian cancer incidence in the United States, 1992-1999.

Authors:  Jeffrey T Quirk; Nachimuthu Natarajan
Journal:  Gynecol Oncol       Date:  2005-05       Impact factor: 5.482

2.  FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread.

Authors:  Johanna Hynninen; Annika Auranen; Olli Carpén; Kirsti Dean; Marko Seppänen; Jukka Kemppainen; Maija Lavonius; Irina Lisinen; Johanna Virtanen; Seija Grénman
Journal:  Gynecol Oncol       Date:  2012-04-24       Impact factor: 5.482

3.  Survival among U.S. women with invasive epithelial ovarian cancer.

Authors:  Valerie McGuire; Christine A Jesser; Alice S Whittemore
Journal:  Gynecol Oncol       Date:  2002-03       Impact factor: 5.482

4.  Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience.

Authors:  J Alexandre; I Ray-Coquard; F Selle; A Floquet; P Cottu; B Weber; C Falandry; D Lebrun; E Pujade-Lauraine
Journal:  Ann Oncol       Date:  2010-05-21       Impact factor: 32.976

Review 5.  Diaphragmatic surgery during cytoreduction for primary or recurrent epithelial ovarian cancer: a review of the literature.

Authors:  Andrea Papadia; Matteo Morotti
Journal:  Arch Gynecol Obstet       Date:  2013-01-23       Impact factor: 2.344

6.  Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.

Authors:  Mary L Gemignani; Alan C Schlaerth; Faina Bogomolniy; Richard R Barakat; Oscar Lin; Robert Soslow; Ennapandam Venkatraman; Jeff Boyd
Journal:  Gynecol Oncol       Date:  2003-08       Impact factor: 5.482

7.  Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment.

Authors:  Viviane Hess; Roger A'Hern; Nazar Nasiri; D Michael King; Peter R Blake; Desmond P J Barton; John H Shepherd; T Ind; J Bridges; K Harrington; Stanley B Kaye; Martin E Gore
Journal:  J Clin Oncol       Date:  2004-03-15       Impact factor: 44.544

8.  Metastatic mucinous ovarian cancer and treatment decisions based on histology and molecular markers rather than the primary location.

Authors:  Angela Jain; Paula D Ryan; Michael V Seiden
Journal:  J Natl Compr Canc Netw       Date:  2012-09       Impact factor: 11.908

9.  Comparison of advanced stage mucinous epithelial ovarian cancer and serous epithelial ovarian cancer with regard to chemosensitivity and survival outcome: a matched case-control study.

Authors:  Emine Karabuk; M Faruk Kose; Deniz Hizli; Salih Taşkin; Burak Karadağ; Taner Turan; Nurettin Boran; Ahmet Ozfuttu; U Fırat Ortaç
Journal:  J Gynecol Oncol       Date:  2013-04-05       Impact factor: 4.401

10.  Pathology of ovarian cancers in BRCA1 and BRCA2 carriers.

Authors:  Sunil R Lakhani; Sanjiv Manek; Frederique Penault-Llorca; Adrienne Flanagan; Laurent Arnout; Samantha Merrett; Lesley McGuffog; Dawn Steele; Peter Devilee; Jan G M Klijn; Hanne Meijers-Heijboer; Paolo Radice; Silvana Pilotti; Heli Nevanlinna; Ralf Butzow; Hagay Sobol; Jocylyne Jacquemier; Dominique Stoppa Lyonet; Susan L Neuhausen; Barbara Weber; Teresa Wagner; Robert Winqvist; Yves-Jean Bignon; Franco Monti; Fernando Schmitt; Gilbert Lenoir; Susanne Seitz; Ute Hamman; Paul Pharoah; Geoff Lane; Bruce Ponder; D Timothy Bishop; Douglas F Easton
Journal:  Clin Cancer Res       Date:  2004-04-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.